260 related articles for article (PubMed ID: 12510993)
1. Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome.
Legro RS
J Pediatr Endocrinol Metab; 2002 Dec; 15 Suppl 5():1367-78. PubMed ID: 12510993
[TBL] [Abstract][Full Text] [Related]
2. Polycystic ovary syndrome in adolescents.
Kent SC; Legro RS
Adolesc Med; 2002 Feb; 13(1):73-88, vi. PubMed ID: 11841956
[TBL] [Abstract][Full Text] [Related]
3. [Early metabolic abnormalities--insulin resistance, hyperinsulinemia, impaired glucose tolerance and diabetes, in adolescent girls with polycystic ovarian syndrome].
Otto-Buczkowska E; Jarosz-Chobot P; Deja G
Przegl Lek; 2006; 63(4):234-8. PubMed ID: 17080748
[TBL] [Abstract][Full Text] [Related]
4. Type 2 diabetes and the polycystic ovary syndrome.
Pelusi B; Gambineri A; Pasquali R
Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
[TBL] [Abstract][Full Text] [Related]
5. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
Legro RS; Castracane VD; Kauffman RP
Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
[TBL] [Abstract][Full Text] [Related]
6. Insulin resistance and metformin in polycystic ovary syndrome.
Ben-Haroush A; Yogev Y; Fisch B
Eur J Obstet Gynecol Reprod Biol; 2004 Aug; 115(2):125-33. PubMed ID: 15262344
[TBL] [Abstract][Full Text] [Related]
7. Effects of metformin therapy on hyperandrogenism in women with polycystic ovarian syndrome.
Kazerooni T; Dehghan-Kooshkghazi M
Gynecol Endocrinol; 2003 Feb; 17(1):51-6. PubMed ID: 12724019
[TBL] [Abstract][Full Text] [Related]
8. Polycystic ovary syndrome in adolescents.
Franks S
Int J Obes (Lond); 2008 Jul; 32(7):1035-41. PubMed ID: 18458678
[TBL] [Abstract][Full Text] [Related]
9. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
10. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
11. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular risk in women with polycystic ovary syndrome.
Giallauria F; Orio F; Palomba S; Lombardi G; Colao A; Vigorito C
J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):987-92. PubMed ID: 18799960
[TBL] [Abstract][Full Text] [Related]
13. Polycystic ovary syndrome in the Indian Subcontinent.
Allahbadia GN; Merchant R
Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
[TBL] [Abstract][Full Text] [Related]
14. Metformin decreases the adipokine vaspin in overweight women with polycystic ovary syndrome concomitant with improvement in insulin sensitivity and a decrease in insulin resistance.
Tan BK; Heutling D; Chen J; Farhatullah S; Adya R; Keay SD; Kennedy CR; Lehnert H; Randeva HS
Diabetes; 2008 Jun; 57(6):1501-7. PubMed ID: 18375437
[TBL] [Abstract][Full Text] [Related]
15. Polycystic ovary syndrome in the adolescent.
Pfeifer SM; Kives S
Obstet Gynecol Clin North Am; 2009 Mar; 36(1):129-52. PubMed ID: 19344852
[TBL] [Abstract][Full Text] [Related]
16. Is metformin a primary ovulatory agent in patients with polycystic ovary syndrome?
Cheang KI; Sharma ST; Nestler JE
Gynecol Endocrinol; 2006 Nov; 22(11):595-604. PubMed ID: 17145645
[TBL] [Abstract][Full Text] [Related]
17. Obese adolescent girls with polycystic ovary syndrome (PCOS) have more severe insulin resistance measured by HOMA-IR score than obese girls without PCOS.
Sawathiparnich P; Weerakulwattana L; Santiprabhob J; Likitmaskul S
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S33-7. PubMed ID: 16856423
[TBL] [Abstract][Full Text] [Related]
18. Treatment options of polycystic ovary syndrome in adolescence.
Zapanti E; Kiapekou E; Loutradis D
Pediatr Endocrinol Rev; 2006 Jan; 3 Suppl 1():208-13. PubMed ID: 16641862
[TBL] [Abstract][Full Text] [Related]
19. Type 2 diabetes and cardiovascular disease in polycystic ovary syndrome: what are the risks and can they be reduced?
Tomlinson J; Millward A; Stenhouse E; Pinkney J
Diabet Med; 2010 May; 27(5):498-515. PubMed ID: 20536945
[TBL] [Abstract][Full Text] [Related]
20. Insulin sensitization early after menarche prevents progression from precocious pubarche to polycystic ovary syndrome.
Ibáñez L; Ferrer A; Ong K; Amin R; Dunger D; de Zegher F
J Pediatr; 2004 Jan; 144(1):23-9. PubMed ID: 14722514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]